EMEA-002138-PIP01-17-M01

Key facts

Active substance
Carotuximab
Therapeutic area
Oncology
Decision number
P/0072/2019
PIP number
EMEA-002138-PIP01-17-M01
Pharmaceutical form(s)
Concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of soft tissue sarcoma
Route(s) of administration
Intravenous use
Contact for public enquiries
TRACON Pharma Limited
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating